For vitreoretinal surgery, the literature results were considered controversial.
“The recommendations for peri-operative management is [sic] similar to that for glaucoma surgery. Anti-thrombotic agents are to be discontinued where possible and to be cautious of these agents in the presence of neovascular retinal diseases,” the study reported.
For oculoplastic and lacrimal surgery, procedures that are carried out posterior to the orbital septum and deep orbital surgery are associated with potentially sight-threatening hemorrhagic complications, and lacrimal surgery also is considered a high-risk procedure. Procedures that are performed anterior to the orbital septum are considered low risk.
The authors stated: “Expert groups on oculoplastic surgery recommend stopping anti-thrombotic agents during blepharoplasty, lacrimal surgery and deep orbital surgery as these are considered high risk for sight-threatening haemorrhagic complications.”
For strabismus surgery, the recommendations are similar to those for glaucoma and vitreoretinal surgeries.
For corneal surgery, no evidence was found.
Hemorrhagic complications were reported in all groups.